NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
Maya Giron joined the Post Bulletin staff in 2023. She grew up in the Berkshires area of Western Massachusetts and recently obtained a BFA in photojournalism from the Rochester Institute of Technology (RIT) in Rochester, N.Y., in the spring of 2023. During her time at RIT she interned at the Pittsburgh Post-Gazette in Pittsburgh, Pa., and the Rapid City Journal in Rapid City, S.D., before making the move to Minnesota.
Maya Giron joined the Post Bulletin staff in 2023. She grew up in the Berkshires area of Western Massachusetts and recently obtained a BFA in photojournalism from the Rochester Institute of Technology (RIT) in Rochester, N.Y., in the spring of 2023. During her time at RIT she interned at the Pittsburgh Post-Gazette in Pittsburgh, Pa., and the Rapid City Journal in Rapid City, S.D., before making the move to Minnesota.